
With endovascular approach, mortality
nonrandomized series
ranged 1.2%-6.7% and complications
of EVT for extensive
ranged 3%-45%. Clinical symptoms
AIOD188
improved in 83% to 100%. Technical
success was achieved in 86% to 100%
of the patients. The 4-year or 5-year
primary and secondary patency rates
were